Stay updated on Psilocybin vs Niacin for Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.

Latest updates to the Psilocybin vs Niacin for Depression Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now presents the PSIL201 long-term follow-up study record, including its design, eligibility, outcomes, and study dates. It reports that the study was terminated because of low enrollment and inability to achieve statistical significance.SummaryDifference32%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence.” It appears above a page displaying a 403 error rather than the study record.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedA new revision tag (Revision: v3.7.0) is shown, and a substantial amount of boilerplate UI text and metadata was removed, simplifying the page without altering the essential study information.SummaryDifference15%

Stay in the know with updates to Psilocybin vs Niacin for Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin vs Niacin for Depression Clinical Trial page.